Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment
TerminatedPhase 4NCT00628355
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Our hypothesis is that with comparison of effectiveness of two most common techniques of treatment for myofascial pain syndrome (injection of local anesthesia and ischemic compression) we could choice the most adequate to treat this disease. This way we could decrease the expenses with medicines, examinations, consultations and the time that women remains without a diagnosis and treatment.
Study details
- Official title
- Local Injection of Lidocaine Versus Ischemic Compression in Treatment of Woman With Chronic Pelvic Pain Caused by Abdominal Myofascial Pain Syndrome: Randomized Clinical Trial.
- Conditions
- Interventions
- Drug: lidocaine
- Procedure: Ischemic compression
- Sponsor
- University of Sao Paulo
- Start date
- 2008-02
- Primary completion
- 2009-10
- Sex
- Female
- Age range
- from 18 Years to 45 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Women with chronic diagnosis of pelvic pain; 2. Women in menacme; 3. Presence of the diagnostic criteria for abdominal myofascial syndrome; 4. Agreement with the Term of Free and Clarified Assent. Exclusion Criteria: 1. Endometriosis, interstitial cystitis, syndrome of the irritable intestine or another illness that it justifies or it contributes for chronic pelvic pain; 2. Endometrioma or hernia evidenced to the ultrasound of the abdominal wall.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00628355